BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/New_York BEGIN:STANDARD DTSTART:20211107T010000 RDATE:20220313T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20221106T010000 RDATE:20230312T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20231105T010000 RDATE:20240310T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20241103T010000 RDATE:20250309T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20251102T010000 RDATE:20260308T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20261101T010000 RDATE:20270314T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20271107T010000 RDATE:20280312T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20281105T010000 RDATE:20290311T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20291104T010000 RDATE:20300310T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20301103T010000 RDATE:20310309T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20311102T010000 RDATE:20320314T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20321107T010000 RDATE:20330313T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20331106T010000 RDATE:20340312T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20341105T010000 RDATE:20350311T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20351104T010000 RDATE:20360309T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20361102T010000 RDATE:20370308T030000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:STANDARD DTSTART:20371101T010000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:America/New_York EST END:STANDARD BEGIN:DAYLIGHT DTSTART:20210330T120000 RDATE:20211107T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20220313T030000 RDATE:20221106T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20230312T030000 RDATE:20231105T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20240310T030000 RDATE:20241103T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20250309T030000 RDATE:20251102T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20260308T030000 RDATE:20261101T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20270314T030000 RDATE:20271107T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20280312T030000 RDATE:20281105T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20290311T030000 RDATE:20291104T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20300310T030000 RDATE:20301103T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20310309T030000 RDATE:20311102T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20320314T030000 RDATE:20321107T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20330313T030000 RDATE:20331106T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20340312T030000 RDATE:20341105T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20350311T030000 RDATE:20351104T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20360309T030000 RDATE:20361102T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT BEGIN:DAYLIGHT DTSTART:20370308T030000 RDATE:20371101T010000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:America/New_York EDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:690009f19506c71dc14361e4c8e5137f CATEGORIES:Student Events CREATED:20220329T110243 SUMMARY:Invitations to Industry - Eleftheria Pissadaki, Manager, Systems Neuroscientist, Biogen Digital Health at Biogen LOCATION:via Zoom DESCRIPTION:Zoom Link (https://us06web.zoom.us/my/erdosinstitute)\nDr. Pissadaki is a deep insight visionary in terdisciplinary neuroscientist and a multirole research manager, leading re search and innovation activities in the fields of neuroscience, complex dat a analysis, digital medicine and blockchain technology. She has experience gained through appointments in world class universities, IT and pharmaceuti cal companies fused into skills and profile structured for pushing science and innovation challenges beyond limits and expectations. \nHer primal visi on is to develop and research ideas, turn them into projects and deliverabl es, and build organizations for impacting and alleviating suffering in heal th conditions. Finding out the right space and mission for leading with ful l dedication on inherently complex problems, while succeeding even when bac kground is limited, or results are deserted. Dr. Pissadaki is an alumna of the University of Crete where she earned her PhD in Computational Neuroscie nce, Neurobiology and her MS in Neuroscience, Neurobiology, and Neuroscienc es. She completed her post-doctoral fellowship at the University of Oxford in Neuroscience.\nBiogen (https://nam02.safelinks.protection.outlook.com/?u rl=https%3A%2F%2Fwww.biogen.com%2F&data=04%7C01%7Cjk1709%40scarletmail. rutgers.edu%7C84f91d1d03df4201c57108da118cd27d%7Cb92d2b234d35447093ff69aca6 632ffe%7C1%7C0%7C637841593759192381%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjA wMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=%2F6UE jvOM%2BB3YpscOX%2F1ThRkX2lONCTRpinwu8J2ns1s%3D&reserved=0): "Through cu tting-edge science and medicine, Biogen discovers, develops and delivers in novative therapies worldwide for people living with serious neurological an d neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biote chnology and today the Company has the leading portfolio of medicines to tr eat multiple sclerosis, has introduced the first and only approved treatmen t for spinal muscular atrophy, and is at the forefront of neurology researc h for conditions including Alzheimer’s disease, Parkinson’s disease and amy otrophic lateral sclerosis. Biogen also manufactures and commercializes bio similars of advanced biologics. With approximately 7000 people worldwide, w e are truly a global organization, headquartered in Cambridge, Massachusett s, which is also home to our research operations. Our international headqua rters are based in Zug, Switzerland and we have world-class manufacturing f acilities in North Carolina and Denmark. We offer therapies globally throug h direct affiliate presence in 30 countries and a network of distribution p artners in over 50 additional countries. For more information, please visit here. Follow us on social media – Twitter, LinkedIn, Facebook, YouTu be."\nFor future Invitations to Industry (i2i) talks, check here (https://w ww.erdosinstitute.org/invitations-to-industry).\n X-ALT-DESC;FMTTYPE=text/html:
Dr. Pissadaki is a deep insight visionary i
nterdisciplinary neuroscientist and a multirole research manager, leading r
esearch and innovation activities in the fields of neuroscience, complex da
ta analysis, digital medicine and blockchain technology. She has experience
gained through appointments in world class universities, IT and pharmaceut
ical companies fused into skills and profile structured for pushing science
and innovation challenges beyond limits and expectations.
Her primal
vision is to develop and research ideas, turn them into projects and deliv
erables, and build organizations for impacting and alleviating suffering in
health conditions. Finding out the right space and mission for leading wit
h full dedication on inherently complex problems, while succeeding even whe
n background is limited, or results are deserted. Dr. Pissadaki is an alumn
a of the University of Crete where she earned her PhD in Computational Neur
oscience, Neurobiology and her MS in Neuroscience, Neurobiology, and Neuros
ciences. She completed her post-doctoral fellowship at the University of Ox
ford in Neuroscience.
Biogen: "Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies wor ldwide for people living with serious neurological and neurodegenerative di seases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis , has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions inclu ding Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral scler osis. Biogen also manufactures and commercializes biosimilars of advanced b iologics. With approximately 7000 people worldwide, we are truly a global o rganization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug , Switzerland and we have world-class manufacturing facilities in North Car olina and Denmark. We offer therapies globally through direct affiliate pre sence in 30 countries and a network of distribution partners in over 50 add itional countries. For more information, please visit here. Foll ow us on social media – Twitter, LinkedIn, Facebook, YouTube."
here